New Parkinson's pill enters first human safety tests
Disease control
Recruiting now
This early-stage study tests a new oral drug called HL-400 in 86 healthy adults to see if it is safe and how the body processes it. The drug aims to reduce inflammation linked to Parkinson's disease. Participants will receive either the drug or a placebo, and researchers will mon…
Phase: PHASE1 • Sponsor: Highlightll Pharmaceutical (USA) LLC • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC